It’s Nobel Prize season—the time of year when scientists speculate who among them will receive one of the most coveted awards ...

The venture capital firm Atlas Venture is launching a start-up that aims to develop antisense oligonucleotides for a ...

Victor Ambros and Gary Ruvkunreceive prize for the discovery of microRNA and its role in post-transcriptional gene regulation ...

Though the topic seems mundane, Jensen tells Newscripts the science is broadly applicable—everyone gets paper cuts—and ...

As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage ...